' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency.
Wolf, F; Gaisberger, C; Ziegler, I; Krenn, E; Scherer, P; Hruby, S; Schätz, T; Forstner, R; Holzinger, J; Vaszi, A; Kametriser, G; Steininger, P; Deutschmann, H; Sedlmayer, F;
Radiother Oncol. 2015; 116(2): 221-225.
Originalarbeiten (Zeitschrift)

PMU-Autor/inn/en

Deutschmann Heinz
Forstner Rosemarie
Gaisberger Christoph
Holzinger Josef
Hruby Stephan
Schätz Tobias
Scherer Philipp
Sedlmayer Felix
Steininger Philipp
Vaszi Andrea
Wolf Frank

Abstract

BACKGROUND AND PURPOSE
In external beam radiation (EBRT) of the prostate, the rectum is the dose-limiting organ at risk, and sparing of the anterior rectal wall is a prerequisite for safe delivery of doses beyond 70Gy. Spatial sparing of the rectum can be achieved by introducing a spacer material into the retroprostatic space, thus separating the anterior rectal wall from the PTV.
Two spacer technologies, Spacer OAR, a polyethylene glycol gel and ProSpace, a saline inflated balloon, were compared in terms of spacer volume, stability, and dose reduction to the anterior rectum wall in 78 patients.
Both spacer systems significantly reduced the rectum surface encompassed by the 95% isodose (gel: -35%, p<0.01; balloon -63.4%, p<0.001) compared to a control group. The balloon spacer was superior in reducing rectum dose (-27.7%, p=0.034), but exhibited an average volume loss of >50% during the full course of treatment of 37-40 fractions, while the volume of gel spacers remained fairly constant.
In choosing between the two spacer technologies, the advantageous dose reduction of the balloon needs to be weighed up against the better volume consistency of the gel spacer with respect to the duration of hypofractionated vs normofractionated regimens.


Find related publications in this database (Keywords)

Prostate
Spacer
Balloon
Rectal sparing
Dose escalation
Hypofractionation